J Korean Med Assoc.  2003 Sep;46(9):800-807. 10.5124/jkma.2003.46.9.800.

Pharmacotherapy in the Treatment of Depression

• Paik IH
• Pae CU

• KMID: 2183120
• DOI: http://doi.org/10.5124/jkma.2003.46.9.800

Abstract

Some new antidepressants including mirtazapine and citalopram appear to have promising efficacy and tolerability in the treatment of depression. For most major depression, all antidepressant drugs have equal efficacy. The choice of antidepressant drug needs to be tailored to a particular patient's medical condition and personal preferences. It is likely that adverse effects are the major determinant in the choice of antidepressant for a particular patient. However, in treating conditions other than depression, the efficacy of the ntidepressant drug can be the primary issue of drug choice. In conclusion, we would like discuss the current status and future direction in the treatment of depression.

Keyword

Pharmacotherapy; Depression

MeSH Terms

Antidepressive Agents
Citalopram
Depression*
Drug Therapy*
Humans
Antidepressive Agents
Citalopram

Reference

1. Anttila SA, Leinonen EV. A review of the pharmacological and clinical profile of mirtazapine. CNS Drug Rev. 2001. 7:249–264.

2. Burrows GD, Maguire KP, Norman TR. Antidepressant efficacy and tolerability of the selective norepinephrine reuptake inhibitor reboxetine : a review. J Clin Psychiatry. 1998. 59:Suppl 14. 4–7.

3. Feighner JP. Mechanism of action of antidepressant medications. J Clin Psychiatry. 1999. 60:Suppl 4. 4–11.

4. Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol. 1997. 17:Suppl 1. 2S–18S.

5. Keck PE Jr, McElroy SL, Strakowski SM. Anticonvulsants and antipsychotics in the treatment of bipolar disorder. J Clin Psychiatry. 1998. 59:Suppl 6. 74–81.

6. Kent JM. SNaRIs, NaSSAs, and NaRIs : new agents for the treatment of depression. Lancet. 2000. 355:911–918.

7. Lenox RH, McNamara RK, Papke RL, Manji HK. Neurobiology of lithium : an update. J Clin Psychiatry. 1998. 59:Suppl 6. 37–47.

8. Licht RW. Drug treatment of mania : a critical review. Acta Psychiatr Scand. 1998. 97(6):387–397.

9. Macdonald KJ, Young LT. Newer antiepileptic drugs in bipolar disorder : rationale for use and role in therapy. CNS Drugs. 2002. 16(8):549–562.

10. Masand PS, Gupta S. Selective serotonin-reuptake inhibitors : an update. Harv Rev Psychiatry. 1999. 7:69–84.

11. Sadock BJ, Sadock VA. Synopsis of Psychiatry. 2003. 9th ed. Philadelphia: Wiliams & Wilkins.

12. Schatzberg AF. Clinical efficacy of reboxetine in major depression. J Clin Psychiatry. 2000. 61:Suppl 10. 31–38.

13. Schatzberg AF, Cole JO, DMH CD. Manual of clinical psychopharmacology. 2003. 4th ed. Washington: American Psychiatric Publishing, Inc.